Search

Your search keyword '"Michael P. Pender"' showing total 214 results

Search Constraints

Start Over You searched for: Author "Michael P. Pender" Remove constraint Author: "Michael P. Pender"
214 results on '"Michael P. Pender"'

Search Results

1. Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy

2. Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

3. Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types

4. Reported Changes in Dietary Behavior Following a First Clinical Diagnosis of Central Nervous System Demyelination

5. Sun Exposure across the Life Course Significantly Modulates Early Multiple Sclerosis Clinical Course

6. Reactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid Disease

7. Interleukin-6 Gene Promoter-572 C Allele May Play a Role in Rate of Disease Progression in Multiple Sclerosis

8. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis

9. Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination

10. A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study

11. Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies

12. ECTRIMS 2019 – Late Breaking News Abstracts

13. Reduced IκB-α Protein Levels in Peripheral Blood Cells of Patients with Multiple Sclerosis—A Possible Cause of Constitutive NF-κB Activation

14. High Prudent diet factor score predicts lower relapse hazard in early multiple sclerosis

15. Mechanisms of neurological dysfunction and recovery in acute experimental allergic encephalomyelitis in the lewis rat

16. Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis

17. Hypothesis: bipolar disorder is an Epstein-Barr virus-driven chronic autoimmune disease - implications for immunotherapy

18. A higher Mediterranean diet score, including unprocessed red meat, is associated with reduced risk of central nervous system demyelination in a case-control study of Australian adults

19. Higher Non-processed Red Meat Consumption Is Associated With a Reduced Risk of Central Nervous System Demyelination

20. Sun exposure across the life course significantly modulates early multiple sclerosis clinical course

21. Incidence and prevalence of NMOSD in Australia and New Zealand

22. Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

23. Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis

24. Stressful life events and the risk of initial central nervous system demyelination

25. Population attributable fractions and joint effects of key risk factors for multiple sclerosis

27. Reported Changes in Dietary Behavior Following a First Clinical Diagnosis of Central Nervous System Demyelination

28. Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis

29. Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis

30. Vitamin D status: Multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradient

31. Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentially

32. Occupational Exposure and Risk of Central Nervous System Demyelination

33. Offspring number, pregnancy, and risk of a first clinical demyelinating event: The AusImmune Study

34. Epstein-Barr virus and multiple sclerosis

35. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination

36. Sun exposure and vitamin D are independent risk factors for CNS demyelination

37. The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis

39. PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations

40. The role of latitude, ultraviolet radiation exposure and vitamin D in childhood asthma and hayfever: an Australian multicenter study

41. Oral Presentations

42. Latitudinal variation in incidence and type of first central nervous system demyelinating events

43. 2009 ACTRIMS ABSTRACTS: Oral Presentations

44. Associations between Silicone Skin Cast Score, Cumulative Sun Exposure, and Other Factors in the Ausimmune Study: A Multicenter Australian Study

45. Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis

46. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis

47. Poster Presentations

48. Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population

49. No association between MTHFR A1298C and MTRR A66G polymorphisms, and MS in an Australian cohort

50. Blood–brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement

Catalog

Books, media, physical & digital resources